TLRY News

NEW YORK and SAVONA, Italy, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, today announced a strategic update to its medical cannabis operations in Italy with the launch of Tilray Medical Italia, the new name of the entity previously known as FL Group.

NEW YORK and LEAMINGTON, Ontario, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage and wellness industries, today announced that the Company will release its financial results for the second fiscal quarter which ended November 30, 2025, after the financial markets close on Thursday, January 8, 2026.

TORONTO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage and wellness industries, announces the launch of Amped Live Resin Liquid Diamond 1g 510 cartridges, marking Redecan’s first live resin–liquid diamond line for the brand. The debut lineup, Space Age CK and Blueberry DNTS, pairs Redecan’s Legit Live Resin with Liquid Diamonds to deliver a true‑to‑strain flavour and aroma in a performance‑engineered 510 vape cartridge.

(NASDAQ:TLRY) BRECKENRIDGE, Colo., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Breckenridge Distillery, an award-winning craft distillery and spirits brand owned by Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), has announced a strategic change in its California distribution approach, appointing Winebow, a respected national partner, to manage distribution responsibilities within the state.

Tilray Affirms Continued Commitment to German Healthcare and Expanding Patient and Pharmacy Access in Europe's Largest Medical Cannabis Market Tilray Affirms Continued Commitment to German Healthcare and Expanding Patient and Pharmacy Access in Europe's Largest Medical Cannabis Market

NEW YORK and LEAMINGTON, Ontario, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today announced that it received written notice from the Nasdaq Stock Market, LLC (“Nasdaq”) confirming that Tilray is again in compliance with Nasdaq’s minimum bid price requirement set forth in 5450(a)(1) of the Nasdaq Listing Rules. To achieve this, the Company’s shares were required to close at $1.00 or higher for at least 10 consecutive trading days. According to Nasdaq’s notice, Tilray maintained a closing bid price of at least $1.00 for 10 consecutive trading days from August 13, 2025 to August 26, 2025, thereby meeting the minimum bid price requirement. As a result, Nasdaq has closed the matter.

Tilray’s FL Group Teams Up with Molteni, a Major Pharmaceutical Firm Focused on Pain and Substance Dependence Therapies Tilray’s FL Group Teams Up with Molteni, a Major Pharmaceutical Firm Focused on Pain and Substance Dependence Therapies

NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (NASDAQ: TLRY and TSX: TLRY) is building on the momentum of its hemp-derived Delta-9 THC (HDD9) beverage portfolio with new 10mg format extensions from its brands: Fizzy Jane’s and Happy Flower.

Tilray's medical arm expands into Germany with launch of Good Supply brand, offering affordable and high-quality cannabis flower. TLRY stock up 2.33%

Tilray shares trade flat as company expands cannabis lineup with XMG Atomic Sours drinks and gummies.

Tilray shares dipped after Blue Point re-released its commuter-themed beer and launched a new whiskey under the Breckenridge brand.

Tilray launches new whiskey. Recently it planned a reverse split to meet Nasdaq listing standards.

Tilray shares are trading lower by 6.2% during Thursday's session. The company on Thursday announced plans to implement a reverse stock split.

Tilray shares fall 6.8% after announcing a proposed reverse stock split ahead of a June 10 shareholder vote.

Tilray Brands Inc. (NASDAQ: TLRY) has launched its first medical cannabis edibles in Australia through Tilray Medical. The new sugar-free, vegan Good Supply Pastilles offer THC and CBD options, enhancing patient access to plant-based therapies.

Tilray Brands missed Q3 revenue expectations and lowered FY25 outlook, while beverage and wellness units posted year-over-year revenue increases.

Tilray Brands transitions its flagship cannabis strain, Good Supply Jean Guy, to Québec.

Tilray Brands shares are slightly higher after a court dismissed a lawsuit. Recently, the company strengthened its partnership with Whole Foods Market by bringing back its energy brand, HiBall Energy, to U.S. retail shelves this spring.

Tilray Brands Inc. (NASDAQ: TLRY) is reintroducing its energy brand, HiBall Energy, to U.S. retail shelves this spring. Known for its zero-calorie and sugar-free beverages, HiBall Sparkling Energy Seltzer Waters offer a health-conscious alternative to traditional energy drinks.

Tilray Brands stock rises after launching Superseed Snack Clusters. It recently expanded its non-alcoholic beer brand, Runner's High Brewing.

Tilray Brands reported 9% YoY revenue growth in Q2 2025 to $210.95 million. Fiscal 2025 guidance remains strong at $950 million-$1 billion in net revenue targets.

Tilray faces a new shareholder lawsuit accusing the company of misleading voting practices, following a $39.9M settlement over similar issues

Tilray Medical launches its first German-grown cannabis products under a new cultivation license, tapping into Germany's expanding market...